Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease

NACompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

June 1, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Sickle Cell Disease
Interventions
BEHAVIORAL

Mobile DOT

Daily reminders via text or email to send a video of themselves taking their Hydroxyurea, positive feedback, and be encouraged to contact the research coordinator with any questions, concerns, etc.

Trial Locations (4)

15224

Children's Hospital of Pittsburgh, Pittsburgh

20010

Children's National Medical Center, Washington D.C.

30322

Children's Healthcare of Atlanta, Atlanta

60607

University of Illinois at Chicago, Chicago

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Emory University

OTHER

NCT02371720 - Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease | Biotech Hunter | Biotech Hunter